SCHEMBL2980735

SCHEMBL2980735

CNC(=O)CN(CC1CCN(CCC#Cc2cc(Cl)ccc2Cl)CC1)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2975120 0.90
SCHEMBL2980822 0.88 GRIN2B (0.44)
SCHEMBL2982101 0.82 DCUN1D1 (0.42)
SCHEMBL2975028 0.81 ARG1 (0.44)
SCHEMBL3598760 0.79 TP53 (0.44)
SCHEMBL3598762 0.79 CCR5 (0.46)
SCHEMBL2980730 0.78 PRCP (0.36)
SCHEMBL2979865 0.77 HTR1A (0.45)
SCHEMBL2970167 0.77 SIGMAR1 (0.49)
Hydrochloric Acid SCHEMBL2971261 0.76 SIGMAR1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781590-B2 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors SANOFI-AVENTIS (FR) 2010-08-24 US disclosed
US-20070021403-A1 PIPERIDINYLALKYLCARBAMATE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THE THERAPEUTIC USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2007-01-25 US disclosed